-
Akanitapichat P, Wangmaneerat A, Wilairat P, Bastowc K F. Anti-herpes virus activity of Dunbaria bella Prain[J]. J Ethnopharmacol, 2006, 105(): 64-68. doi: 10.1016/j.jep.2005.09.035
-
Baker J T, Borris R P, Carte B. Natural product drug discovery and development: new perspectives on international collaboration[J]. J Nat Prod, 1995, 58(): 1325-1357. doi: 10.1021/np50123a003
-
Boehmer P E, Lehman I R. Herpes simplex virus DNA replication[J]. Annu. Rev. Biochem, 1997, 66(): 347-384. doi: 10.1146/annurev.biochem.66.1.347
-
Brinker A M, Ma J, Lipsky P E. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)[J]. Phytochemistry, 2007, 68(): 732-766. doi: 10.1016/j.phytochem.2006.11.029
-
Cheng H Y, Lin C C, Lin T C. Antiherpes simplex virus type 2 activity of casuarinin from the bark of Terminalia arjuna Linn[J]. Antiviral Res, 2002, 55(): 447-455. doi: 10.1016/S0166-3542(02)00077-3
-
Chang L C, Chang W, Chang M Y. Antiviral activity of Plantago major extracts and related compounds in vitro[J]. Antiviral Res, 2002, 55(): 53-62. doi: 10.1016/S0166-3542(02)00007-4
-
Coen D M. Antiviral drug resistance in herpes simplex virus[J]. Adv Exp Med Biol, 1996, 394(): 49-57. doi: 10.1007/978-1-4757-9209-6
-
Duan H Q, Takaishi Y, Imakura Y. Sesquiterpene alkaloids from Tripterygium hypoglaucum and Tripterygium wilfordii: a new class of potent anti-HIV agents[J]. J Nat Prod, 2000, 63(): 357-361. doi: 10.1021/np990281s
-
Fritz D, Venturi C R, Cargnin S. Herpes virus inhibitory substances from Hypericum connatum Lam., a plant used in southern Brazil to treat oral lesions[J]. J Ethnopharmacol, 2007, 113(): 517-520. doi: 10.1016/j.jep.2007.07.013
-
Fujita R, Duan H, Takaishi Y. Terpenoids from Tripterigyum hypoglaucum[J]. Phytochemisty, 2000, 53(6): 715-722. doi: 10.1016/S0031-9422(99)00557-9
-
Kimberlin D W, Whitley R J. Antiviral resistance: mechanisms, clinical significance, and future implications[J]. J Antimicrob Chemoth, 1996, 37(): 403-421. doi: 10.1093/jac/37.3.403
-
Kleymann G. Novel agents and strategies to treat herpes simplex infections[J]. Expert Opin Invest Drugs, 2003, 12(): 165-183. doi: 10.1517/13543784.12.2.165
-
Mosmann T. Rapid colorimetric assay for cellular growth survival: Application to proliferation and cytoxicity assays[J]. J Immunol Methods, 1983, 65(): 55-63. doi: 10.1016/0022-1759(83)90303-4
-
Patwardhan B, Gautam M. Botanical immunodrugs: scope and opportunities[J]. Drug Discov Today, 2005, 10(): 495-502. doi: 10.1016/S1359-6446(04)03357-4
-
Reed L J, Muench H. A simple method for estimating fifty percent end points[J]. Am J Hygiene, 1938, 27(): 493-497.
-
Roizman B. HSV gene function: what have we learned that could be generally applicable to its near and distant cousins?[J]. Acta virol, 1999, 43(): 75-80.
-
Roizman B, Sears A E.1990. Herpes simples virus and their replication. In: Virology (Fields B N, Knipe D M, Howley P M, et al. eds.), 2nd ed. New York: Raven Press, p 1795-1841.
-
Smith J S, Robinson N J. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review[J]. J Infect Dis, 2002, 186(Suppl. 1): S3-S28.
-
Subak-Sharpe J H, Dargan D J. HSV molecular biology: general aspects of herpes simplex virus molecular biology[J]. Virus Genes, 1998, 16(): 239-251. doi: 10.1023/A:1008068902673
-
Tao J, Hu Q X, Yang J, Li R R. In vitro anti-HIV and-HSV activity and safety of sodium rutin sulfate as a microbicide candidate[J]. Antiviral Res, 2007, 75(): 227-233. doi: 10.1016/j.antiviral.2007.03.008
-
Vlietinck A J, Vanden Berghe D A. Can ethnopharmacology contribute to the development of antiviral drugs?[J]. J Ethnopharmacol, 1991, 32(): 141-153. doi: 10.1016/0378-8741(91)90112-Q
-
Wang R R, Gu Q, Yang L M. Anti-HIV-1 activities of extracts from the medicinal plant Rhus chinensis[J]. J Ethnopharmacol, 2006, 105(): 269-273. doi: 10.1016/j.jep.2005.11.008
-
Whtley R J, Kimberlin D W, Roizman B. Herpes simplex viruses[J]. Clin Infect Dis, 1998, 26(): 541-553. doi: 10.1086/cid.1998.26.issue-3
-
Zhang C H, Wang Y F, Liu X J. Antiviral activity of cepharanthine against severe acute respiratory syndrome coronavirus in vitro[J]. Chin Med J, 2005, 118(): 493-496.